Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Apr 28, 2026
Reporting period
Not applicable
Filed with the SEC
Apr 30, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001140361-26-018352
Filed / recorded
Apr 30, 2026, 11:06 PM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
HCA Healthcare, Inc.
Issuer CIK
860730
Ticker
HCA
Reporting person
Thomas F Iii Frist
Relationship
Director, 10% owner
Security
Common Stock, par value $0.01 per share
Table
Non-derivative (Table I)
Transaction date
Apr 28, 2026
Transaction code
A
Shares / units
1,041
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
15,858
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer") underlying 509 restricted share units attributable to an annual director equity award and 532 restricted share units received in lieu of annual cash retainers for service as a director and as Chairman of the Board. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested Shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of the Issuer.
